证券记录 · 已归档季度
ACLX
Arcellx, Inc. · Healthcare · Biotechnology
13被追踪持有人
+2Δ持有人
5.38M持有股份
$412.92M报告持仓市值
+4新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +18.2% ·
股份流向 +5.2% ·
净新建仓位 +15.4%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 79 | -11 | 20.14M | $2.28B | +11 | −23 |
| Q4 2025 | 90 | +2 | 26.91M | $1.75B | +4 | −1 |
| Q3 2025 | 15 | -1 | 21.54M | $1.77B | — | −2 |
| Q2 2025 | 14 | -2 | 18.84M | $1.24B | — | −2 |
| Q1 2025 | 13 | 0 | 6.16M | $404.16M | +1 | −1 |
| Q4 2024 | 13 | +2 | 5.38M | $412.92M | +4 | −2 |
| Q3 2024 | 10 | +1 | 3.34M | $279.00M | +2 | −1 |
| Q2 2024 | 9 | — | 3.07M | $169.41M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.12M | +11.6% | $162.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.12M | +11.6% | $162.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 1.78M | — | $136.15M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 979.03K | +0.4% | $75.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 979.03K | +0.4% | $75.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Capital World Investors ✦ | 252.88K | 新增 | $19.39M | 0.0% | New | 1 | SEC ↗ |
| 7 | Duquesne Family Office ✦ | 74.10K | 0.0% | $5.68M | 0.2% | Held | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 49.10K | 新增 | $3.77M | 0.0% | New | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (被动) | 27.25K | 新增 | $2.09M | 0.0% | New | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 25.23K | +47.6% | $1.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 22.37K | 新增 | $1.72M | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 20.25K | +22.4% | $1.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 20.25K | +22.4% | $1.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 20.25K | +22.4% | $1.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 19.69K | -6.1% | $1.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 19.69K | -6.1% | $1.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 19.69K | -6.1% | $1.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 19.69K | -6.1% | $1.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 10.51K | -19.2% | $805,859 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 6.90K | -72.5% | $529,161 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Capital World Investors | $19.39M | 0.0% |
| Renaissance Technologies | $3.77M | 0.0% |
| Norges Bank | $2.09M | 0.0% |
| Millennium Management | $1.72M | 0.0% |
已清仓
| Adage Capital Partners | $24.39M | 曾为 0.0% |
| D. E. Shaw & Co. | $526,531 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 236 持有人, 55.96M 股份, $5.94B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据